{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:07:11Z","timestamp":1791259631565,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neurological sequelae of coronavirus disease 2019 (COVID-19) include inflammatory myelopathies. Among these, magnetic resonance imaging (MRI)-negative myelitis\u2014 defined as normal spinal cord MRI findings despite compatible clinical features\u2014presents diagnostic and therapeutic challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 22-year-old Japanese woman developed progressive distal paresthesia, gait disturbance, bladder and rectal dysfunction, and sensory loss approximately three months after COVID-19. Neurological examination presented with pyramidal tract signs and sensory deficits in both lower limbs. Cerebrospinal fluid oligoclonal bands were positive. Brain MRI showed subtle corticospinal tract hyperintensities, whereas spinal MRI findings remained normal throughout the course. Somatosensory-evoked potentials (SEP) demonstrated absent right N20 and bilateral P37 responses, localizing dysfunction to the thoracic cord. Treatment with intravenous methylprednisolone pulse therapy with plasma exchange resulted in marked clinical recovery and SEP normalization, with only mild residual paresthesia at two-year follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The present case illustrates the clinical utility of SEPs for monitoring disease activity and establishing objective criteria for treatment escalation in post-COVID-19 MRI-negative myelitis. Although MRI-negative myelitis can be observed in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), lupus myelitis, and glial fibrillary acidic protein (GFAP) astrocytopathy, post-COVID-19 myelitis lacks specific biomarkers, complicating both diagnosis and treatment. A review of 20 reported cases of post-COVID-19 MRI-negative myelitis revealed a mean age of 54.4 years, a male-to-female ratio of 3:2, frequent bladder and rectal disturbances and paresis (85% each), high severity (63.2%), a median infection-to-neurological interval of 28 days, oligoclonal bands in 25% (4\/16), multiple immunotherapies in 66.7%, and marked improvement or recovery in 66.7%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In post-COVID-19 MRI-negative myelitis, SEPs offer critical diagnostic and prognostic information. Early recognition and timely escalation of combination immunotherapy may optimize neurological outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1708018","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T07:14:30Z","timestamp":1765350870000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["MRI-negative myelitis, especially after COVID-19: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Mitsuyoshi","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoki","family":"Hanayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumoto","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1275696","article-title":"Case report: MRI-negative myelitis following COVID-19 with SEP abnormalities: a case series and literature review","volume":"14","author":"Kawama","year":"2023","journal-title":"Front Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3588-24","article-title":"Magnetic resonance imaging\/cerebrospinal fluid-negative myelitis following COVID-19 with a dramatic response to early aggressive immunosuppressive therapy","volume":"63","author":"Okumura","year":"2024","journal-title":"Intern Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12883-022-02837-5","article-title":"Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report","volume":"22","author":"Kolcava","year":"2022","journal-title":"BMC Neurol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S267000","article-title":"Suspected transverse myelitis with normal MRI and CSF findings in a patient with lupus: what to do? A case series and systematic review","volume":"16","author":"Monahan","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.993645","article-title":"Neuroimaging features in inflammatory myelopathies: A review","volume":"13","author":"Cacciaguerra","year":"2022","journal-title":"Front Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12618","article-title":"Post-varicella anti-myelin oligodendrocyte glycoprotein antibody-associated magnetic resonance imaging-negative myelitis","volume":"12","author":"Viswanathan","year":"2021","journal-title":"Clin Exp Neuroimmunology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-248921","article-title":"Radiographic evolution of myelitis in a case of glial fibrillary acidic protein (GFAP) astrocytopathy","volume":"16","author":"Goyne","year":"2023","journal-title":"BMJ Case Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00389","article-title":"Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis","volume":"3","author":"Yamano","year":"2012","journal-title":"Front Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19334-0","article-title":"The immune control and cell-to-cell spread of human T-lymphotropic virus type 1","volume":"84","author":"Bangham","year":"2003","journal-title":"J Gen Virol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"100481","DOI":"10.1016\/j.ensci.2023.100481","article-title":"MRI-negative myelitis associated with MOG-IgG antibody: A case report and literature reviews","volume":"33","author":"Yang","year":"2023","journal-title":"eNeurologicalSci"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1177\/1352458519840746","article-title":"MOG-related disorders: A new cause of imaging-negative myelitis","volume":"26","author":"Macaron","year":"2020","journal-title":"Mult Scler"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2329048x19830475","DOI":"10.1177\/2329048X19830475","article-title":"MRI-negative myelitis associated with myelin oligodendrocyte glycoprotein antibody spectrum demyelinating disease","volume":"6","author":"P\u00e9rez","year":"2019","journal-title":"Child Neurol Open"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2022.0433","article-title":"A case of MRI-negative encephalomyelitis in a patient with long-term stable myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"19","author":"Hwangbo","year":"2023","journal-title":"J Clin Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520907900","article-title":"Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies","volume":"27","author":"Sechi","year":"2021","journal-title":"Mult Scler"},{"key":"B15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.17161\/rrnmf.v6i1.21721","article-title":"Diagnostic and treatment challenges in MRI-negative myelitis associated with MOG antibody: A case report and literature review","volume":"6","author":"Ortiz-Guerrero","year":"2025","journal-title":"RRNMF Neuromuscular J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"109111","DOI":"10.1016\/j.clineuro.2025.109111","article-title":"Repeated MRI-negative demyelinating attacks linked to MOG-IgG antibodies and silent lesions - Case series and literature review","volume":"257","author":"Friedman-Korn","year":"2025","journal-title":"Clin Neurol Neurosurg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"005467","DOI":"10.12890\/2025_005467","article-title":"Unmasking myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): CNS demyelination triggered by TNF-\u03b1 Inhibition in a patient with ankylosing spondylitis","volume":"12","author":"Baddam","year":"2025","journal-title":"Eur J Case Rep Intern Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14746","article-title":"The long-term outcome of MOGAD: An observational national cohort study of 61 patients","volume":"28","author":"Deschamps","year":"2021","journal-title":"Eur J Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.968322","article-title":"Persistent \u201cMRI-negative\u201d lupus myelitis-disease presentation, immunological profile and outcome","volume":"13","author":"Das","year":"2022","journal-title":"Front Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4103\/aian.aian_654_24","article-title":"MRI-negative central nervous system SLE: A unique case report","volume":"28","author":"Grover","year":"2025","journal-title":"Ann Indian Acad Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-021-00986-w","article-title":"MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis","volume":"27","author":"Abrams","year":"2021","journal-title":"J Neurovirol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2024-000730","article-title":"\u2018Grasshopper sign\u2019: the novel imaging of post-COVID-19 myelopathy with delayed longitudinal white matter abnormalities","volume":"6","author":"Okumura","year":"2024","journal-title":"BMJ Neurol Open"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-250535","article-title":"MRI-negative myelitis associated with cerebral venous thrombosis after COVID-19 infection","volume":"15","author":"Masaad","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"106513","DOI":"10.1016\/j.clineuro.2021.106513","article-title":"Late-onset rapidly progressive MRI- negative-myelitis after COVID-19 illness","volume":"202","author":"Memon","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41393-020-0493-8","article-title":"Transient acute-onset tetraparesis in a COVID-19 patient","volume":"58","author":"Giorgianni","year":"2020","journal-title":"Spinal Cord"},{"key":"B28","doi-asserted-by":"publisher","first-page":"102305","DOI":"10.1016\/j.dsx.2021.102305","article-title":"MRI-negative myeloradiculoneuropathy following Covid-19 infection: An index case","volume":"15","author":"Metya","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09997-9","article-title":"Transverse myelitis related to COVID-19 infection","volume":"267","author":"Zachariadis","year":"2020","journal-title":"J Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e23054","DOI":"10.7759\/cureus.23054","article-title":"Spastic paraparesis after SARS-CoV-2 infection without radiological changes","volume":"14","author":"Zukic","year":"2022","journal-title":"Cureus"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/ncn3.12544","article-title":"Anti-myelin oligodendrocyte glycoprotein antibody-associated disease presenting MRI-negative myelitis and papilledema","volume":"9","author":"Goto","year":"2021","journal-title":"Neurol Clin Neurosci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1398028","article-title":"Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies","volume":"15","author":"Bellucci","year":"2024","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000456","article-title":"Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis","volume":"5","author":"Takewaki","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cell.2020.08.028","article-title":"Effects of COVID-19 on the nervous system","volume":"183","author":"Iadecola","year":"2020","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-020-04374-x","article-title":"SARS-CoV-2 can induce brain and spine demyelinating lesions","volume":"162","author":"Zanin","year":"2020","journal-title":"Acta Neurochir (Wien)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38051","article-title":"A comparison between somatosensory evoked potentials and spine MRI in the diagnosis of non-compressive myelopathy: which is more accurate","volume":"15","author":"Mohammed","year":"2023","journal-title":"Cureus"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1708018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T07:14:31Z","timestamp":1765350871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1708018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2025.1708018"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1708018","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"article-number":"1708018"}}